Lantern Pharma (LTRN) Institutional Ownership $4.99 -0.15 (-2.92%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$5.02 +0.03 (+0.52%) As of 08/7/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lantern Pharma (NASDAQ:LTRN)CurrentInstitutional OwnershipPercentage28.62%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$4.38MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$441.61K Get LTRN Insider Trade Alerts Want to know when executives and insiders are buying or selling Lantern Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LTRN Institutional Buying and Selling by Quarter Lantern Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/5/2025 Westside Investment Management Inc.35,900$113K0.0%+17.1%0.333% 5/16/2025NewEdge Advisors LLC59,924$212K0.0%-12.3%0.556% 4/23/2025 Perigon Wealth Management LLC39,387$139K0.0%+169.8%0.365% 2/17/2025Two Sigma Investments LP16,545$53K0.0%-51.8%0.153% 2/14/2025Voss Capital LP50,000$160K0.0%N/A0.464% 2/13/2025NewEdge Advisors LLC68,359$218K0.0%-50.2%0.634% 2/13/2025Renaissance Technologies LLC87,300$278K0.0%+3.9%0.810% 2/10/2025BIOS Capital Management LP1,207,709$3.85M4.1%N/A11.203% 2/7/2025CM Management LLC200,000$638K0.6%+8.1%1.855% 1/31/2025Sanctuary Advisors LLC10,000$32K0.0%N/A0.093% Get the Latest News and Ratings for LTRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lantern Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/24/2025 DAVENPORT & Co LLC25,814$82K0.0%-52.0%0.239% 1/22/2025 Perigon Wealth Management LLC14,600$47K0.0%-49.5%0.135% 11/20/2024 Westside Investment Management Inc.30,650$112K0.0%+166.5%0.284% 8/9/2024Renaissance Technologies LLC81,800$382K0.0%+24.5%0.760% 8/9/2024Dimensional Fund Advisors LP18,413$86K0.0%+55.7%0.171% 8/2/2024CM Management LLC80,000$374K0.3%+23.1%0.743% 7/17/2024 Westside Investment Management Inc.11,500$54K0.0%N/A0.107% 5/14/2024CM Management LLC65,000$572K0.5%-18.8%0.604% 5/10/2024Tocqueville Asset Management L.P.19,000$167K0.0%N/A0.177% 4/10/2024 Pathway Financial Advisors LLC25,001$220K0.1%-12.3%0.233% 2/12/2024 Redmond Asset Management LLC40,662$174K0.1%-12.6%0.374% 2/8/2024Meridian Wealth Management LLC19,660$84K0.0%+18.0%0.181% 2/1/2024 Sigma Planning Corp11,875$51K0.0%-34.5%0.109% 2/1/2024 Pathway Financial Advisors LLC28,501$122K0.0%-13.0%0.262% 10/30/2023 Pathway Financial Advisors LLC32,771$112K0.0%+134.1%0.302% 10/17/2023Meridian Wealth Management LLC16,660$57K0.0%N/A0.153% 8/10/2023Carlson Capital L P95,000$536K0.0%-23.9%0.875% 8/4/2023CM Management LLC75,000$423K0.4%+25.0%0.691% 7/19/2023 Pathway Financial Advisors LLC14,001$79K0.0%N/A0.129% 2/9/2023CM Management LLC60,000$362K0.4%+20.0%0.552% 2/9/2023 Wolff Wiese Magana LLC27,098$164K0.1%-11.0%0.250% 2/7/2023Lynwood Capital Management Inc.12,000$73K0.1%N/A0.110% 11/15/2022Carlson Capital L P168,000$803K0.1%-1.2%1.547% 11/4/2022CM Management LLC50,000$239K0.3%+10.9%0.462% 8/8/2022CM Management LLC45,100$258K0.3%+33.6%0.416% 7/15/2022 Wolff Wiese Magana LLC31,575$180K0.1%-12.7%0.292% 7/11/2022 Sanders Morris Harris LLC366,030$2.06M0.5%-4.7%3.379% 5/9/2022CM Management LLC33,765$241K0.2%N/A0.312% 5/9/2022 Wolff Wiese Magana LLC36,155$259K0.2%+5.9%0.334% 4/11/2022 Sanders Morris Harris LLC384,228$2.75M0.5%+14.2%3.564% Crypto bros: Meet your replacement (Ad)Larry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% worldwide. Now he’s applying the same expertise to the Bitcoin market. His system tracks 19 indicators to find quick Bitcoin profit opportunities.Now he’s revealing the entire thing… FREE.2/4/2022 Envestnet Asset Management Inc.10,542$84K0.0%N/A0.094% 2/4/2022 Redmond Asset Management LLC49,187$393K0.1%+3.7%0.440% 2/3/2022Advisor Group Holdings Inc.5,331$43K0.0%+92.5%0.048% 2/2/2022 Sanders Morris Harris LLC336,425$2.57M0.4%N/A3.007% 2/2/2022 Sigma Planning Corp17,600$140K0.0%N/A0.157% 1/14/2022 Spire Wealth Management4,050$32K0.0%+285.7%0.036% 11/9/2021BlackRock Inc.23,074$258K0.0%-8.1%0.206% 11/5/2021Advisor Group Holdings Inc.2,770$31K0.0%+177.0%0.025% 11/2/2021Raymond James & Associates25,879$289K0.0%N/A0.231% 10/29/2021GWM Advisors LLC155,859$1.74M0.0%+3.0%1.394% 10/22/2021 Redmond Asset Management LLC47,442$530K0.2%+4.3%0.424% 10/15/2021 Wolff Wiese Magana LLC35,316$395K0.3%+24.7%0.316% 8/16/2021Corriente Advisors LLC656,364$9.58M5.2%-8.0%5.869% 8/13/2021Geode Capital Management LLC55,479$809K0.0%+21.1%0.496% 8/13/2021Vanguard Group Inc.269,429$3.93M0.0%+4.0%2.409% 8/11/2021 Bank of New York Mellon Corp26,765$391K0.0%+127.3%0.239% 7/31/2021GWM Advisors LLC151,316$2.21M0.1%N/A1.353% 5/21/2021Citadel Advisors LLC11,192$203K0.0%N/A0.100% 5/18/2021Millennium Management LLC42,106$764K0.0%N/A0.377% 5/18/2021Morgan Stanley50,702$920K0.0%+81.6%0.453% (Data available from 1/1/2016 forward) LTRN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LTRN shares? During the previous two years, 17 institutional investors and hedge funds held shares of Lantern Pharma. The most heavily invested institutionals were BIOS Capital Management LP ($3.85M), CM Management LLC ($638K), Carlson Capital L P ($536K), Renaissance Technologies LLC ($278K), Pathway Financial Advisors LLC ($220K), NewEdge Advisors LLC ($212K), and Redmond Asset Management LLC ($174K).Learn more on Lantern Pharma's institutional investors. What percentage of Lantern Pharma's stock is owned by institutional investors? 28.62% of Lantern Pharma's stock is owned by institutional investors. Learn more on LTRN's institutional investor holdings. Which institutional investors have been buying Lantern Pharma's stock? Of the 11 institutional investors that purchased Lantern Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BIOS Capital Management LP ($1.21M), Voss Capital LP ($50K), Westside Investment Management Inc. ($35.90K), CM Management LLC ($30K), Perigon Wealth Management LLC ($24.79K), Meridian Wealth Management LLC ($19.66K), and Renaissance Technologies LLC ($19.40K). How much institutional buying is happening at Lantern Pharma? Institutional investors have bought a total of 1,357,881 shares in the last 24 months. This purchase volume represents approximately $4.38M in transactions. Which of Lantern Pharma's major shareholders have been selling company stock? The following institutional investors have sold Lantern Pharma stock in the last 24 months: NewEdge Advisors LLC ($77.41K), DAVENPORT & Co LLC ($28K), Two Sigma Investments LP ($17.80K), and Perigon Wealth Management LLC ($14.30K). How much institutional selling is happening at Lantern Pharma? Institutional investors have sold a total of 137,509 shares in the last 24 months. This volume of shares sold represents approximately $441.61K in transactions. Related Companies YMAB Major Shareholders EDIT Major Shareholders ELDN Major Shareholders MDWD Major Shareholders AVTE Major Shareholders IPHA Major Shareholders ENGN Major Shareholders GNFT Major Shareholders CTMX Major Shareholders EPRX Major Shareholders This page (NASDAQ:LTRN) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lantern Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lantern Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
